Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Formamide | HCID 713 | — |
| Reactant | Water | HCID 962 | — |
| Reactant | Sarmazenil | HCID 71231 | — |
| Reactant | Sodium Methoxide | HCID 10942334 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 14590422 | HCID 14590422 | — |
Reaction Steps
22.8 g Ethyl 7-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate were suspended under stirring and argon atmosphere in 91.2 ml 1,4-dioxane. 14.1 ml Formamide and 13.9 ml sodium methanolate were successively added to yield a clear light-orange solution, which turned to a white suspension after 10 minutes. This suspension was stirred two hours at 30° C. 200 ml Deionized water were added in one portion and 1,4-dioxane was distilled off at 40° C. under reduced pressure. The remaining white suspension was stirred two hours at 0° C. and filtered. The precipitate (7-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide) was washed with 50 ml deionized water three times and dried under reduced pressure for 18 hours at 80° C. Crude product:19.43 g as a white powder. m.p. >250° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06281353B1 |
|---|
| Source dataset | uspto-grants-2001_08 |
|---|
| ORD ID | ord-511484f7f5014ef5b36beb7d1bb1b2c1 |
|---|
| Source note | uspto-grants-2001_08 |
|---|